Virtual Human Delivered Nutrition Module for Colorectal Cancer Prevention
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04192071 |
Recruitment Status :
Recruiting
First Posted : December 10, 2019
Last Update Posted : February 12, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Colorectal Cancer | Other: virtual technology - high interactive Other: virtual technology - low interactive Other: non-colorectal cancer related module | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 180 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Participant) |
Primary Purpose: | Screening |
Official Title: | Adapting and Pilot Testing a Nutrition Module Delivered With Virtual Human Technology for Colorectal Cancer Prevention |
Actual Study Start Date : | January 6, 2020 |
Estimated Primary Completion Date : | January 2022 |
Estimated Study Completion Date : | January 2022 |
Arm | Intervention/treatment |
---|---|
Active Comparator: high interactive virtual human administered nutrition module
The virtual health assistant will interactively collect nutrition information (alcohol, red meat, and processed meat intake) and report risk information back to users in visual and audio format
|
Other: virtual technology - high interactive
Participants engage with web-based cancer prevention content and answer a short series of questions designed to assess their baseline risk for colon cancer and dietary intake. Interactive nutrition risk feedback will be customized based on user input.
Other Name: Virtual human nutrition module |
Active Comparator: low interactive virtual human module
Complete the current intervention module that includes items assessing alcohol and meat intake.
|
Other: virtual technology - low interactive
Participants engage with web-based cancer prevention content and answer a short series of questions designed to assess their baseline risk for colon cancer. Minimally interactive risk feedback will be delivered.
Other Name: virtual human standard |
Sham Comparator: attention control module
The attention control group, will complete a related module not related to colorectal cancer or nutrition
|
Other: non-colorectal cancer related module
Participants engage with web-based content not related to colorectal cancer or nutrition.
Other Name: attention control |
- Risk perceptions for colorectal cancer [ Time Frame: up to 2 hours ]Items measured on a 10-point Likert scale, (e.g. "My chances of getting colorectal cancer are high")
- Intentions to screen for colorectal cancer [ Time Frame: up to 2 hours ]Items measured on a 10-point Likert scale, (e.g. "I want to get screened for colorectal cancer")
- Information seeking behavior [ Time Frame: up to 2 hours ]Does participant click on link to more information. The survey platforms event tracking feature will be used to track clicks (yes/no) for more information.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 50 Years to 73 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Eligible adults will be between 50-73 years old,
- Proficient in English and
- Geographically residing rural areas of north central Florida.
Exclusion Criteria:
-

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04192071
Contact: Melissa Vilaro, PhD | 352-846-3014 | mgraveley@ufl.edu |
United States, Florida | |
University of Florida | Recruiting |
Gainesville, Florida, United States, 32611 | |
Contact: Melissa Vilaro, PhD | |
Principal Investigator: Melissa Vilaro, PhD |
Principal Investigator: | Melissa Vilaro, PhD | University of Florida |
Responsible Party: | University of Florida |
ClinicalTrials.gov Identifier: | NCT04192071 |
Other Study ID Numbers: |
IRB201902537-N 3R01CA207689-03S2 ( U.S. NIH Grant/Contract ) OCR27722 ( Other Identifier: UF OnCore ) |
First Posted: | December 10, 2019 Key Record Dates |
Last Update Posted: | February 12, 2021 |
Last Verified: | February 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Nutrition |
Colorectal Neoplasms Intestinal Neoplasms Gastrointestinal Neoplasms Digestive System Neoplasms Neoplasms by Site Neoplasms |
Digestive System Diseases Gastrointestinal Diseases Colonic Diseases Intestinal Diseases Rectal Diseases |